What is LetsGetChecked?
LetsGetChecked operates a sophisticated medical technology platform designed to bridge the gap between consumers and a global network of laboratories. The company specializes in providing accessible personal at-home health testing, enabling individuals to monitor their well-being conveniently. Headquartered in New York, NY, LetsGetChecked has established itself as a key innovator in the health tech space, leveraging technology to democratize health diagnostics and empower individuals with actionable health insights.
How much funding has LetsGetChecked raised?
LetsGetChecked has raised a total of $263M across 4 funding rounds:
Series A
$12M
Series C
$71M
Series B
$30M
Series D
$150M
Series A (2018): $12M with participation from Optum Ventures
Series C (2020): $71M led by CommonFund Capital, Illumina Ventures, HLM Venture Partners, Deerfield, Optum Ventures, Angeles Investments, Qiming Venture Partners USA, and Transformation Capital
Series B (2020): $30M, investors not publicly disclosed
Series D (2021): $150M featuring Casdin Capital
Key Investors in LetsGetChecked
Illumina Ventures
Illumina Ventures is a leader in genomics and precision health investing, focused on building an ecosystem that translates investment into innovation to enhance human health. The company supports various portfolio companies that are advancing life science research, biopharmaceutical drug development, and gene editing technologies.
Deerfield
Deerfield Management is an investment firm focused on advancing healthcare through investment, intelligence, and philanthropy. The firm supports companies across the healthcare ecosystem with flexible funding models and drives innovation using AI, data, and market research.
Optum Ventures
Optum Ventures was created to make health care better for everyone. We invest in early-stage companies that are poised to disrupt the status quo.
What's next for LetsGetChecked?
With the recent infusion of $150M in a major strategic investment, LetsGetChecked is poised for accelerated growth and market penetration. This enterprise-level funding suggests a focus on scaling operations, expanding its testing portfolio, and enhancing its technological infrastructure. The company is likely to further solidify its position as a leader in the direct-to-consumer health testing market, potentially exploring new diagnostic areas and strengthening its global laboratory partnerships to meet increasing demand for personalized health solutions.
See full LetsGetChecked company page
